Sant Celoni, Spain

Rafael García Cruz

This inventor holds 1 USPTO granted patent. Top assignee: Medichem, S.a.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rafael García Cruz. Retrieved from https://idiyas.com/inventor/rafael-garcandiacutea-cruz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rafael García Cruz: Innovator in Pharmaceutical Development

Introduction

Rafael García Cruz is a notable inventor based in Sant Celoni, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of gabapentin formulations. His innovative work has led to advancements in the production processes of pharmaceutical-grade compounds.

Latest Patents

Rafael holds a patent for a "Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine." This patent describes a method for preparing a non-hydrated gabapentin polymorph by drying an aqueous solution of gabapentin through spray drying or turbo-drying. The resulting polymorph is utilized in the crystallization process from solvents to produce pharmaceutical-grade gabapentin. He has 1 patent to his name.

Career Highlights

Rafael is currently employed at Medichem, S.A., where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Throughout his career, Rafael has collaborated with several professionals, including Jordi Bosch Lladó and Elias Molins Grau. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Rafael García Cruz exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of gabapentin production, highlight the importance of research and development in creating effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…